Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling

por Mullershausen, Florian, Friebe, Andreas, Feil, Robert, Thompson, W. Joseph, Hofmann, Franz, Koesling, Doris
Publicado 2003

Rapid nitric oxide–induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme

por Mullershausen, Florian, Russwurm, Michael, Thompson, W. Joseph, Liu, Li, Koesling, Doris, Friebe, Andreas
Publicado 2001

Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria

por Nishimura, Jun-ichi, Ando, Kiyoshi, Masuko, Masayoshi, Noji, Hideyoshi, Ito, Yoshikazu, Mayer, Jiri, Griskevicius, Laimonas, Bucher, Christoph, Müllershausen, Florian, Gergely, Peter, Rozenberg, Izabela, Schubart, Anna, Chawla, Raghav, Rondeau, Jean-Michel, Roguska, Michael, Splawski, Igor, Keating, Mark T., Johnson, Leslie, Danekula, Rambabu, Bagger, Morten, Watanabe, Yoko, Haraldsson, Börje, Kanakura, Yuzuru
Publicado 2021